unfortunately the ASX is a fairly small market which enables manipulation without much effort, just resources and moderate algorithms by 2nd tier fundies will have the desired affect predominately playing on FOMO, and a narrative of partnerships etc, greed erodes wealth. Mesoblast has certainly changed the paradigm with new generation stem cell treatments providing far better chances of survival than what the traditional archaic treatments pharmaceutical companies have been peddling this why the mega pharmaceutical companies invest significant funds to their research departments seeking innovation to achieve a moat, they will eventually find the pathway to Mesoblast and this is what I'm concerned of most, an opportunistic takeover as I'm sceptical on GG's modus operandi.
MSB Price at posting:
$3.17 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)